M. L. Barnett

Most-cited papers

1. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial.

   M. L. Barnett, Joel M. Kremer, E. S. St Clair, D. O. Clegg +8 more

   1998Arthritis & Rheumatism217 citations

   Semantic Scholar

   Save

2. The prevalence of periodontitis and dental caries in a Down's syndrome population.

   M. L. Barnett, K. Press, D. Friedman, E. Sonnenberg

   1986The Journal of Periodontology138 citations

   Semantic Scholar

   Save

3. Provision of health care for persons with developmental disabilities living in the community. The Morristown model.

   P. Ziring, T. Kastner, D. L. Friedman, William S. Pond +3 more

   1988Journal of the American Medical Association (JAMA)53 citations

   Semantic Scholar

   Save

4. The prevalence of mitral valve prolapse in patients with Down's syndrome: implications for dental management.

   M. L. Barnett, D. Friedman, T. Kastner

   1988Oral surgery, oral medicine, and oral pathology31 citations

   Semantic Scholar

   Save

5. Dental treatment program for patients with mental retardation.

   M. L. Barnett, P. Ziring, D. Friedman, E. Sonnenberg

   1988Mental Retardation11 citations

   Semantic Scholar

   Save

6. Phase II evaluation of piroxantrone in renal cell carcinoma. A Southwest Oncology Group Study.

   A. Allen, M. Wolf, E. Crawford, M. Davis +2 more

   1992Investigational new drugs2 citations

   Semantic Scholar

   Save

7. Cachexia in a Mentally Retarded Adolescent Secondary to Mandibular Dislocation

   E. Sonnenberg, M. L. Barnett, K. Strassburger, P. Ziring

   1985Developmental Medicine & Child Neurology2 citations

   Semantic Scholar

   Save

8. ARTHRITIS WITH ORAL TYPE I 1 COLLAGEN Results of a Multicenter , Double-Blind , Placebo-Controlled Trial

   M. L. Barnett, J. Kremer, E. S. St Clair, Daniel +10 more

   20050 citations

   Semantic Scholar

   Save

9. Phase II evaluation of piroxantrone in renal cell carcinoma

   A. Allen, M. Wolf, E. Crawford, M. Davis +2 more

   1992Investigational new drugs0 citations Open access

   Semantic Scholar

   Save